🔎 Trials Near Me

Gara Jalqabaatti › Smoldering Multiple Myeloma › New York

Qorannoo klinikaalii Smoldering Multiple Myeloma New York keessatti

Qorannoo 8 Smoldering Multiple Myeloma f New York keessatti hirmaatuu jiru.

Magaalota New York keessatti

Takkalaa qorannoo (Ingiliffa)

A Study of a Plant-Based Diet and Dietary Supplements in People With Smoldering Multiple Myeloma (SMM) or Monoclonal Gammopathy of Undetermined Significance (MGUS)

  • Memorial Sloan Kettering Suffolk - Commack (Limited Protocol Activities), Commack
  • Memorial Sloan Kettering Westchester (All Protocol Activities), Harrison
  • Memorial Sloan Kettering Cancer Center (All Protocol Activities), New York
  • fi 1 dabalataa
Namoota walitti qabaa jira
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 05-Onk-2026 · NCT06055894

A Study to Compare Linvoseltamab and Daratumumab Treatment in High-Risk Smoldering Multiple Myeloma (HR-SMM)

  • Memorial Sloan Kettering Cancer Center, New York
Namoota walitti qabaa jiraSadarkaa 3
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 25-Ful-2026 · NCT07393282

Lenalidomide, and Dexamethasone With or Without Daratumumab in Treating Patients With High-Risk Smoldering Myeloma

  • Hematology Oncology Associates of CNY at Camillus, Camillus
  • Hematology Oncology Associates of Central New York-East Syracuse, East Syracuse
  • Mount Sinai Chelsea, New York
  • fi 2 dabalataa
Namoota walitti qabaa jiraSadarkaa 3
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 19-Hag-2026 · NCT03937635

A Proof-of-Concept Study to Learn Whether Linvoseltamab Can Eliminate Abnormal Plasma Cells That May Lead to Multiple Myeloma in Adult Patients With High-Risk Monoclonal Gammopathy of Undetermined Significance or Non-High-Risk Smoldering Multiple Myeloma

  • NYU Langone Health Perlmutter Cancer Center, New York
  • Stony Brook University Hospital, Stony Brook
Namoota walitti qabaa jiraSadarkaa 2
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 08-Ado-2026 · NCT06140524

A Study Comparing a Plant-Based Diet With Supplements and Placebo in People With Monoclonal Gammopathy of Undetermined Significance (MGUS) or Smoldering Multiple Myeloma (SMM)

  • Memorial Sloan Kettering Suffolk- Commack (All Protocol Activities), Commack
  • Memorial Sloan Kettering Westchester (All Protocol Activities), Harrison
  • Memorial Sloan Kettering Cancer Center (All Protocol Activities), New York
  • fi 1 dabalataa
Namoota walitti qabaa jira
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 16-Elb-2026 · NCT05640843

Non-chemotherapeutic Interventions for the Improvement of Quality of Life and Immune Function in Patients With Multiple Myeloma

  • Roswell Park Cancer Institute, Buffalo
Namoota walitti qabaa jira
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 01-Mud-2025 · NCT05312255

Screening for AL Amyloidosis in Smoldering Multiple Myeloma

  • Columbia University Irving Medical Center, New York
  • Memorial Sloan Kettering Cancer Center, New York
Namoota walitti qabaa jiraQorannoo ilaalaa
Umuriin 40 fi ol · Saalaa hunda · Haaromfame 06-Hag-2025 · NCT06365060

Selinexor for the Treatment of Intermediate and High-Risk Smoldering Multiple Myeloma

  • University of Rochester, Rochester
Namoota walitti qabaa jiraSadarkaa 2
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 10-Gur-2025 · NCT05597345

Kanneen ClinicalTrials.gov irraa argaman, daataa 06-Onk-2026 irratti argame. Qorannoon hundi isaa kan ofii qajeelfama qoodfannaa qaba; gareen qorannoo eenyu akka hirmaatu murteessa.